Last €53.00 EUR
Change Today +0.88 / 1.69%
Volume 26.0
2BH On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:50 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

hca holdings inc (2BH) Snapshot

Open
€51.88
Previous Close
€52.12
Day High
€53.30
Day Low
€51.88
52 Week High
08/29/14 - €53.30
52 Week Low
09/2/13 - €28.54
Market Cap
22.9B
Average Volume 10 Days
37.3
EPS TTM
--
Shares Outstanding
432.4M
EX-Date
12/13/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HCA HOLDINGS INC (2BH)

hca holdings inc (2BH) Details

HCA Holdings, Inc., through its subsidiaries, provides health care services. The company owns, operates, or manages hospitals; freestanding surgery centers; diagnostic and imaging centers; radiation and oncology therapy centers; rehabilitation and physical therapy centers; and various other facilities. Its general, acute care hospitals provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services, as well as outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company’s psychiatric hospitals offer therapeutic programs comprising child, adolescent, and adult psychiatric care, as well as adult and adolescent alcohol and drug abuse treatment and counseling. Its general, acute care hospitals provide a range of services to accommodate medical specialties, such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics, and obstetrics, as well as diagnostic and emergency services. As of December 31, 2013, the company operated 165 hospitals consisting of 159 general, acute care hospitals, 5 psychiatric hospitals, and 1 rehabilitation hospital, as well as 115 freestanding surgery centers in the United States and England. HCA Holdings, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Founded in 1968

hca holdings inc (2BH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $900.0K
President of Operations
Total Annual Compensation: $850.0K
President of National Group
Total Annual Compensation: $750.0K
President of American Group
Total Annual Compensation: $729.2K
Chief Medical Officer and President of Clinic...
Total Annual Compensation: $700.0K
Compensation as of Fiscal Year 2013.

hca holdings inc (2BH) Key Developments

HCA Holdings, Inc. Announces Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revised Earnings Guidance for the Year 2014

HCA Holdings, Inc. announced consolidated earnings results for the second quarter and six months ended June 30, 2014. Revenues in the second quarter increased to $9.230 billion, compared to $8.450 billion in the second quarter of 2013. Net income attributable to HCA Holdings, Inc. totaled $483 million, or $1.07 per diluted share, compared to $423 million, or $0.91 per diluted share, in the second quarter of 2013. Income before income taxes was $904 million against $806 million reported last year. Adjusted EBITDA totaled $2.0 billion compared to $1.689 billion in the second quarter of 2013. Adjusted EBITDA is a non-GAAP financial measure. Net income attributable to company, excluding losses (gains) on sales of facilities, losses on retirement of debt and legal claim costs was $619 million or $1.37 per diluted share against $420 million or $0.91 per diluted share reported last year. Cash flows provided by operating activities in the quarter totaled $1.250 billion compared to $814 million in the second quarter of 2013. Revenues for the six months ended June 30, 2014 totaled $18.062 billion compared to $16.890 billion in the same period of 2013. Net income attributable to HCA Holdings, Inc. was $830 million, or $1.82 per diluted share, compared to $767 million, or $1.66 per diluted share, for the first six months of 2013. Income before income taxes was $1,584 million against $1,445 million reported last year. Adjusted EBITDA was $3,644 million against $3,257 million reported last year. Net income attributable to company, excluding losses (gains) on sales of facilities, losses on retirement of debt and legal claim costs was $1,002 million or $2.20 per diluted share against $768 million or $1.70 per diluted share reported last year. Net cash provided by operating activities was $1,693 million against $1,554 million reported last year. Purchase of property and equipment was $913 million against $896 million reported last year. For the year, the company expects revenues in the range of $36.00 - $36.50 billion compared to previous revenue guidance range of $35.50 - $36.50 billion. Adjusted EBITDA is expected in the range of $7.00 - $7.15 billion against previous range of $6.60 - $6.85 billion. Adjusted EPS (diluted) is expected in the range of $4.00- $4.25 against previous range of $3.45- $3.75. Capital expenditure is expected approximately $2.2 billion.

HCA Holdings, Inc., Q2 2014 Earnings Call, Jul 29, 2014

HCA Holdings, Inc., Q2 2014 Earnings Call, Jul 29, 2014

HCA Holdings, Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2014; Revises Earnings Guidance for the Year 2014

HCA Holdings, Inc. provided earnings guidance for the second quarter ended June 30, 2014 and revised earnings guidance for the year 2014. The company anticipates revenues for the second quarter of 2014 will be approximately $9.230 billion compared to $8.450 billion in the second quarter of 2013. Income before income taxes for the second quarter is expected to approximate $904 million compared to $806 million in the prior year period. Net income per diluted share for the second quarter of 2014 is expected to be approximately $1.07 per diluted share compared to $0.91 for the second quarter of 2013. Adjusted EBITDA for the second quarter is expected to be approximately $2.000 billion compared to $1.689 billion in the previous year's second quarter. The company revised earnings guidance for the year 2014. For the year 2014, the company expects revenues of $36.00 billion to $36.50 billion from $35.50 billion to $36.50 billion as previously guided. Adjusted EBITDA expects to be $7.00 billion to $7.15 billion from $6.60 billion to $6.85 billion as previously guided. Diluted adjusted EPS was expects to be $4.00 per share to $4.25 per share compared to $3.45 per share to $3.75 per share as previously guided. Capital expenditures expects to be approximately $2.2 billion.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2BH:GR €53.00 EUR +0.88

2BH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2BH.
View Industry Companies
 

Industry Analysis

2BH

Industry Average

Valuation 2BH Industry Range
No financial data is available for 2BH.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HCA HOLDINGS INC, please visit www.hcahealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.